Responses
Extended report
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?
Compose a Response to This Article
Other responses
No responses have been published for this article.